Definitive Healthcare Corp. (NASDAQ:DH – Get Free Report) shares reached a new 52-week low during mid-day trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $10.00 to $8.00. Canaccord Genuity Group currently has a hold rating on the stock. Definitive Healthcare traded as low as $4.38 and last traded at $4.89, with a volume of 1416771 shares trading hands. The stock had previously closed at $7.25.
Other equities analysts have also issued research reports about the company. Stifel Nicolaus lowered their target price on Definitive Healthcare from $11.00 to $9.50 and set a “buy” rating on the stock in a research note on Wednesday. Needham & Company LLC reiterated a “hold” rating on shares of Definitive Healthcare in a research note on Wednesday. Barclays raised their price objective on Definitive Healthcare from $10.00 to $11.00 and gave the stock an “equal weight” rating in a research note on Friday, March 1st. Finally, Morgan Stanley lowered Definitive Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the stock from $11.50 to $9.00 in a research note on Wednesday. Eight research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $10.81.
View Our Latest Stock Analysis on DH
Institutional Investors Weigh In On Definitive Healthcare
Definitive Healthcare Price Performance
The firm has a market capitalization of $630.18 million, a P/E ratio of -3.01, a price-to-earnings-growth ratio of 6.12 and a beta of 1.41. The business has a 50-day moving average of $7.70 and a 200 day moving average of $8.29. The company has a current ratio of 2.31, a quick ratio of 2.31 and a debt-to-equity ratio of 0.20.
Definitive Healthcare (NASDAQ:DH – Get Free Report) last issued its quarterly earnings data on Wednesday, February 28th. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02). The company had revenue of $65.93 million for the quarter, compared to the consensus estimate of $66.01 million. Definitive Healthcare had a positive return on equity of 0.43% and a negative net margin of 80.40%. On average, sell-side analysts predict that Definitive Healthcare Corp. will post 0.11 earnings per share for the current fiscal year.
Definitive Healthcare Company Profile
Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.
Read More
- Five stocks we like better than Definitive Healthcare
- Following Congress Stock Trades
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- How to Capture the Benefits of Dividend Increases
- Generac Powers Ahead on the Electrification Mega-Trend
- How to Use Stock Screeners to Find Stocks
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Definitive Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Definitive Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.